Stock Track | Impact Therapeutics-B Soars 65.67% on Trading Debut as IPO Sees Massive Oversubscription

Stock Track

05/13

Impact Therapeutics-B's stock soared 65.67% intraday on its first day of trading on the Hong Kong Stock Exchange.

The sharp rise was driven by extraordinary investor demand during the company's initial public offering. The Hong Kong public offering was oversubscribed 2,282.4 times, while the international offering was 24.58 times subscribed. The company raised approximately HK$759.5 million in net proceeds from the IPO, with the final offer price set at HK$20.10 per H-share.

The stock opened at HK$35.5 per share, representing a significant premium to the IPO price, reflecting strong market confidence in the commercialization-stage biotech company focused on synthetic lethality-based precision oncology therapies.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/1175801097"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1175801097\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1175801097?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-13 09:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1175801097","market":"nz","top_or_hot":-1,"title":"Stock Track | Impact Therapeutics-B Soars 65.67% on Trading Debut as IPO Sees Massive Oversubscription","media":"Stock Track","content":"<p>Impact Therapeutics-B's stock soared 65.67% intraday on its first day of trading on the Hong Kong Stock Exchange.</p><p>The sharp rise was driven by extraordinary investor demand during the company's initial public offering. The Hong Kong public offering was oversubscribed 2,282.4 times, while the international offering was 24.58 times subscribed. The company raised approximately HK$759.5 million in net proceeds from the IPO, with the final offer price set at HK$20.10 per H-share.</p><p>The stock opened at HK$35.5 per share, representing a significant premium to the IPO price, reflecting strong market confidence in the commercialization-stage biotech company focused on synthetic lethality-based precision oncology therapies.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Impact Therapeutics-B Soars 65.67% on Trading Debut as IPO Sees Massive Oversubscription</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Impact Therapeutics-B Soars 65.67% on Trading Debut as IPO Sees Massive Oversubscription\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-05-13 09:33</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Impact Therapeutics-B's stock soared 65.67% intraday on its first day of trading on the Hong Kong Stock Exchange.</p><p>The sharp rise was driven by extraordinary investor demand during the company's initial public offering. The Hong Kong public offering was oversubscribed 2,282.4 times, while the international offering was 24.58 times subscribed. The company raised approximately HK$759.5 million in net proceeds from the IPO, with the final offer price set at HK$20.10 per H-share.</p><p>The stock opened at HK$35.5 per share, representing a significant premium to the IPO price, reflecting strong market confidence in the commercialization-stage biotech company focused on synthetic lethality-based precision oncology therapies.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"07630","symbol_name":"英派药业-B","start_time":0,"source_url":"","article_id":"1175801097","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1175801097","pubTimestamp":1778636029,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Impact Therapeutics-B's stock soared 65.67% intraday on its first day of trading on the Hong Kong Stock Exchange.The sharp rise was driven by extraordinary investor demand during the company's...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"07630":"英派药业-B"},"translate_title":"个股追踪|Impact Therapeutics-B首次交易飙升65.67%IPO获大规模超额认购","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"07630":1},"content_text":"Impact Therapeutics-B's stock soared 65.67% intraday on its first day of trading on the Hong Kong Stock Exchange.The sharp rise was driven by extraordinary investor demand during the company's initial public offering. The Hong Kong public offering was oversubscribed 2,282.4 times, while the international offering was 24.58 times subscribed. The company raised approximately HK$759.5 million in net proceeds from the IPO, with the final offer price set at HK$20.10 per H-share.The stock opened at HK$35.5 per share, representing a significant premium to the IPO price, reflecting strong market confidence in the commercialization-stage biotech company focused on synthetic lethality-based precision oncology therapies.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}